(Note: For PDF File Swipe To The End Of Article)
Introduction to Peptic Ulcer Disease
Peptic ulcer disease (PUD) is a common gastrointestinal disorder characterized by the development of a break or ulcer in the lining of the stomach or duodenum. These ulcers occur when the protective mechanisms of the gastrointestinal mucosa are overwhelmed by damaging factors, particularly gastric acid and pepsin. Although acid plays an important role in ulcer formation, modern understanding recognizes that peptic ulcer disease usually results from an imbalance between aggressive factors and mucosal defense mechanisms.
The two major forms of peptic ulcer disease are gastric ulcers, which occur in the stomach, and duodenal ulcers, which occur mainly in the first part of the small intestine, known as the duodenum. Both conditions may produce similar symptoms, particularly upper abdominal pain, but they differ in their relationship with meals, underlying mechanisms, associated complications, and clinical implications.
Historically, stress and spicy foods were considered major causes of peptic ulcers. However, the discovery of Helicobacter pylori revolutionized the understanding and management of this disease. Today, infection with H. pylori and the use of nonsteroidal anti-inflammatory drugs (NSAIDs) are recognized as the two most important causes of peptic ulcer disease worldwide. Other contributing factors include smoking, severe physiological stress, excessive alcohol consumption, certain medications, and rare conditions associated with excessive gastric acid production.
Peptic ulcer disease remains clinically important because ulcers may cause serious complications. These include gastrointestinal bleeding, perforation, penetration into adjacent organs, and gastric outlet obstruction. Some complications can rapidly become life-threatening and require urgent medical or surgical intervention. Therefore, early recognition of symptoms, identification of risk factors, appropriate diagnostic evaluation, and effective treatment are essential.
Anatomy and Physiology of Gastric Protection
To understand peptic ulcer disease, it is important to understand how the stomach and duodenum normally protect themselves from gastric acid.
The stomach produces hydrochloric acid through specialized cells called parietal cells. Gastric acid plays several important physiological roles. It assists in protein digestion, activates pepsinogen into pepsin, and helps destroy microorganisms entering the gastrointestinal tract. Pepsin is a digestive enzyme that breaks proteins into smaller components.
Despite the highly acidic environment of the stomach, the gastric mucosa normally remains protected. This protection depends on several defense mechanisms.
The surface of the gastric mucosa is covered by a layer of mucus. This mucus acts as a physical barrier between gastric acid and epithelial cells. Bicarbonate is secreted into the mucus layer, creating a relatively neutral microenvironment immediately adjacent to the mucosal surface.
The epithelial cells of the stomach are also connected by tight junctions, which prevent hydrogen ions from easily penetrating into deeper tissues. Rapid cellular repair and regeneration further protect the mucosa when minor injury occurs.
Adequate blood flow is another essential component of mucosal defense. Blood supplies oxygen and nutrients to gastric cells and helps remove toxic substances. Reduced mucosal blood flow can impair healing and increase susceptibility to injury.
Prostaglandins play a particularly important protective role. They stimulate mucus and bicarbonate secretion, maintain mucosal blood flow, and promote epithelial repair. NSAIDs can reduce prostaglandin production, thereby weakening mucosal defenses and increasing the risk of ulcer formation.
In the duodenum, bicarbonate secreted from the pancreas and Brunner glands helps neutralize acidic gastric contents entering from the stomach. If excessive acid enters the duodenum or protective mechanisms are impaired, duodenal ulceration may develop.
Thus, peptic ulcer disease develops when aggressive factors such as acid, pepsin, H. pylori, and NSAIDs overcome protective mechanisms including mucus, bicarbonate, prostaglandins, blood flow, and epithelial repair.
Types of Peptic Ulcers
The major types of peptic ulcers are gastric ulcers and duodenal ulcers.
Gastric Ulcers
Gastric ulcers occur within the stomach. They may develop in different regions but are commonly found along the lesser curvature, particularly near the junction between the body and antrum.
Gastric ulcers are particularly important clinically because some gastric ulcers may be associated with malignancy. Therefore, patients with gastric ulcers often require endoscopic evaluation and, when indicated, biopsy to exclude gastric cancer.
Pain from gastric ulcers may worsen shortly after eating because food stimulates gastric acid secretion and distends the stomach. As a result, some patients may avoid eating and experience weight loss.
Duodenal Ulcers
Duodenal ulcers most commonly occur in the first portion of the duodenum, known as the duodenal bulb.
The pain associated with duodenal ulcers may improve temporarily after eating because food can buffer gastric acid. However, symptoms may return several hours later when the stomach empties and acid enters the duodenum. Nocturnal pain is also relatively common.
Patients with duodenal ulcers may sometimes gain weight because eating temporarily relieves discomfort.
Although these patterns are traditionally described, symptoms can vary considerably, and the relationship between meals and pain alone cannot reliably distinguish gastric from duodenal ulcers.
Major Causes of Peptic Ulcer Disease
Helicobacter pylori Infection
Helicobacter pylori is one of the most important causes of peptic ulcer disease. It is a spiral-shaped, gram-negative bacterium capable of colonizing the gastric mucosa.
The stomach is normally a highly acidic environment, but H. pylori survives by producing an enzyme called urease. Urease breaks down urea into ammonia and carbon dioxide. The ammonia helps neutralize acid in the immediate environment surrounding the bacterium, allowing it to survive within the mucus layer.
The infection causes chronic inflammation of the gastric mucosa. This inflammation weakens protective mechanisms and may alter gastric acid secretion. In some individuals, increased acid delivery to the duodenum contributes to the development of duodenal ulcers.
H. pylori infection is associated with chronic gastritis, peptic ulcer disease, gastric mucosa-associated lymphoid tissue lymphoma, and an increased risk of gastric adenocarcinoma.
Transmission is believed to occur primarily through oral-oral or fecal-oral routes. Infection is more common in areas with overcrowding, poor sanitation, and limited access to clean water.
Not every person infected with H. pylori develops an ulcer. Disease development depends on bacterial factors, host immune responses, gastric acid secretion, environmental influences, and other risk factors.
Nonsteroidal Anti-Inflammatory Drugs
NSAIDs are another major cause of peptic ulcer disease. Common NSAIDs include drugs such as ibuprofen, naproxen, diclofenac, and aspirin.
These medications inhibit cyclooxygenase enzymes involved in prostaglandin synthesis. Reduced prostaglandin production leads to decreased mucus secretion, reduced bicarbonate secretion, impaired mucosal blood flow, and decreased epithelial repair.
As a result, the gastrointestinal mucosa becomes more vulnerable to injury from acid and pepsin.
NSAID-induced ulcers may occur without significant warning symptoms. Some patients may develop gastrointestinal bleeding as the first manifestation of ulcer disease.
The risk is increased in patients who use high doses of NSAIDs, take multiple NSAIDs simultaneously, are older, have a previous history of peptic ulcers, use corticosteroids or anticoagulants, or have serious medical illnesses.
Low-dose aspirin may also increase the risk of gastrointestinal ulceration and bleeding, particularly when combined with other medications that affect bleeding risk.
Other Causes and Risk Factors
Although H. pylori and NSAID use account for the majority of cases, several additional factors can contribute to peptic ulcer development.
Smoking is associated with impaired ulcer healing and increased recurrence. Tobacco use may reduce mucosal blood flow and interfere with protective mechanisms.
Alcohol can irritate the gastrointestinal mucosa and may worsen symptoms. Heavy alcohol consumption may contribute to mucosal injury, although alcohol alone is not considered a major cause of most chronic peptic ulcers.
Severe physiological stress can cause acute stress-related mucosal injury. This may occur in critically ill patients with severe burns, major trauma, sepsis, shock, respiratory failure, or extensive surgery. These ulcers differ somewhat from typical chronic peptic ulcers and may develop rapidly.
Certain medications may increase ulcer or bleeding risk. These include corticosteroids when combined with NSAIDs, anticoagulants, antiplatelet drugs, and selective serotonin reuptake inhibitors in certain high-risk situations.
Rare conditions associated with excessive gastric acid secretion can also cause recurrent or severe ulcers. One important example is Zollinger-Ellison syndrome, in which gastrin-producing tumors called gastrinomas cause excessive acid production.
A family history of ulcer disease, advanced age, previous ulcer history, and multiple medical comorbidities may also increase susceptibility.
Pathophysiology of Peptic Ulcer Formation
The fundamental mechanism behind peptic ulcer disease is an imbalance between mucosal injury and mucosal defense.
Aggressive factors include:
- Gastric acid
- Pepsin
- H. pylori
- NSAIDs
- Bile reflux in selected situations
- Severe physiological stress
Protective factors include:
- Mucus secretion
- Bicarbonate secretion
- Prostaglandins
- Adequate mucosal blood flow
- Intact epithelial cells
- Tight cellular junctions
- Rapid mucosal regeneration
When damaging factors become excessive or protective mechanisms are weakened, mucosal inflammation and erosion occur. If the injury extends through the muscularis mucosae, it is classified as an ulcer.
An erosion is generally more superficial, whereas an ulcer penetrates deeper into the gastrointestinal wall.
In H. pylori-associated disease, chronic inflammation disrupts normal mucosal function. The bacterium produces several substances that contribute to tissue injury and inflammation. Changes in gastrin and somatostatin regulation may alter acid secretion.
In NSAID-associated disease, prostaglandin inhibition is central to ulcer formation. Reduced protective prostaglandins weaken the mucosal barrier, allowing acid and pepsin to damage tissue.
Ulcers may heal with appropriate treatment, but continued exposure to the underlying cause can lead to recurrence.
Clinical Features and Symptoms
The most common symptom of peptic ulcer disease is epigastric pain, meaning pain located in the upper central abdomen.
The pain may be described as burning, gnawing, aching, or hunger-like. It may occur intermittently and may vary in intensity.
Some patients experience pain related to meals. Gastric ulcer pain may worsen after eating, whereas duodenal ulcer pain may improve temporarily after food and return later. However, these classical patterns are not always present.
Other possible symptoms include:
- Bloating
- Early satiety
- Nausea
- Belching
- Indigestion
- Upper abdominal discomfort
- Reduced appetite
- Vomiting in complicated cases
Some patients with peptic ulcers have no symptoms at all until complications develop.
Weight loss may occur, particularly in patients with gastric ulcers who avoid food because eating worsens pain.
Persistent vomiting may suggest gastric outlet obstruction.
Sudden severe abdominal pain may indicate perforation and requires immediate medical attention.
Black, tarry stools known as melena may indicate upper gastrointestinal bleeding. Vomiting blood, known as hematemesis, is another serious warning sign.
Alarm Features Requiring Urgent Evaluation
Certain symptoms raise concern for serious disease or complications and require prompt medical assessment.
Important alarm features include:
- Vomiting blood
- Black or tarry stools
- Severe sudden abdominal pain
- Unexplained weight loss
- Persistent vomiting
- Difficulty swallowing
- Progressive weakness
- Iron deficiency anemia
- Fainting or dizziness
- Signs of shock
- New symptoms in an older patient with significant risk factors
Gastrointestinal bleeding can cause weakness, dizziness, palpitations, low blood pressure, and collapse.
Perforation can cause severe generalized abdominal pain and a rigid abdomen due to leakage of gastrointestinal contents into the peritoneal cavity.
These conditions should be considered medical emergencies.
History Taking in Peptic Ulcer Disease
A careful clinical history provides important information.
The clinician should ask about the location, character, severity, duration, and timing of abdominal pain.
Questions regarding meals are useful. The patient may be asked whether eating worsens or improves symptoms and whether pain occurs at night.
Medication history is extremely important. The use of NSAIDs, aspirin, corticosteroids, anticoagulants, and antiplatelet drugs should be assessed.
A history of previous ulcers or gastrointestinal bleeding should be documented.
Symptoms such as vomiting, weight loss, melena, hematemesis, and anemia should be actively investigated.
Smoking and alcohol use may also be relevant.
Family history of gastrointestinal malignancy can influence the need for further investigation.
The clinician should also consider alternative diagnoses such as gastroesophageal reflux disease, gastritis, gallbladder disease, pancreatitis, functional dyspepsia, and cardiac ischemia.
Physical Examination
Physical examination findings may be normal in uncomplicated peptic ulcer disease.
Some patients experience mild epigastric tenderness.
Signs of gastrointestinal bleeding may include pallor, tachycardia, hypotension, and evidence of anemia.
Severe abdominal rigidity and guarding may suggest perforation.
Signs of dehydration may occur in patients with persistent vomiting.
Physical examination is important, but a normal examination does not exclude significant ulcer disease.
Diagnosis of Peptic Ulcer Disease
The diagnosis of peptic ulcer disease may involve clinical assessment, laboratory testing, H. pylori testing, and endoscopic examination.
Upper Gastrointestinal Endoscopy
Upper gastrointestinal endoscopy is one of the most important diagnostic procedures for peptic ulcer disease.
During endoscopy, a flexible instrument is passed through the mouth into the esophagus, stomach, and duodenum.
Endoscopy allows direct visualization of ulcers and can identify their location, size, depth, and associated bleeding.
It also allows tissue biopsy when necessary.
Biopsy is particularly important for gastric ulcers because malignancy must sometimes be excluded.
Endoscopy can also provide therapeutic treatment for actively bleeding ulcers through techniques such as injection therapy, thermal coagulation, and mechanical clipping.
Helicobacter pylori Testing
Several tests are available for detecting H. pylori infection.
Urea Breath Test
The urea breath test is a highly useful noninvasive method.
The patient consumes specially labeled urea. If H. pylori is present, bacterial urease breaks down the urea, producing labeled carbon dioxide that can be detected in the breath.
This test can be used for diagnosis and for confirming eradication after treatment.
Stool Antigen Test
The stool antigen test detects H. pylori proteins in fecal material.
It is another useful noninvasive method for detecting active infection and confirming eradication after treatment.
Endoscopic Biopsy Testing
When endoscopy is performed, biopsy specimens can be tested for H. pylori using rapid urease testing, histological examination, or other laboratory methods.
Serological Testing
Blood antibody tests may detect previous exposure to H. pylori, but they are less useful for determining whether active infection is currently present because antibodies may remain positive after eradication.
Important Considerations Before Testing
Certain medications can affect the accuracy of H. pylori tests.
Proton pump inhibitors can suppress bacterial activity and may cause false-negative results with some tests.
Antibiotics and bismuth-containing medications can also interfere with testing.
Therefore, medication history should be considered when planning diagnostic testing and confirming eradication.
Clinical guidelines may vary regarding the appropriate interval for withholding medications before testing, so testing should be performed according to local recommendations and medical guidance.
Laboratory Investigations
Laboratory tests may be performed depending on the patient's symptoms and clinical condition.
A complete blood count can identify anemia caused by chronic or acute gastrointestinal bleeding.
Hemoglobin levels may be reduced in patients with significant blood loss.
Iron studies may demonstrate iron deficiency in patients with chronic occult bleeding.
Blood urea nitrogen may increase during upper gastrointestinal bleeding because digested blood proteins contribute to increased nitrogen absorption.
Electrolyte levels may be affected in patients with prolonged vomiting or dehydration.
Liver function tests and pancreatic enzyme measurements may be useful when alternative diagnoses are being considered.
Medical Treatment of Peptic Ulcer Disease
Treatment depends on the underlying cause, severity of symptoms, presence of complications, and H. pylori status.
The major goals of treatment are:
- Relief of symptoms
- Healing of the ulcer
- Elimination of H. pylori when present
- Prevention of recurrence
- Prevention of complications
- Reduction of medication-related injury
Proton Pump Inhibitors
Proton pump inhibitors, commonly called PPIs, are among the most effective medications for reducing gastric acid secretion.
Examples include:
- Omeprazole
- Esomeprazole
- Pantoprazole
- Lansoprazole
- Rabeprazole
PPIs inhibit the gastric hydrogen-potassium ATPase enzyme system, also called the proton pump, in parietal cells.
This significantly reduces gastric acid production and creates an environment that promotes ulcer healing.
PPIs are used in gastric ulcers, duodenal ulcers, NSAID-associated ulcers, and bleeding peptic ulcers.
They may also be used as part of combination therapy for H. pylori eradication.
The duration of treatment depends on the type and severity of the ulcer and its underlying cause.
Histamine-2 Receptor Blockers
Histamine-2 receptor blockers reduce gastric acid secretion by blocking histamine receptors on parietal cells.
Examples include famotidine and other agents in this class.
These medications can promote ulcer healing but are generally less potent than proton pump inhibitors for significant acid suppression.
They may be useful in selected patients depending on clinical circumstances.
Antacids
Antacids neutralize existing gastric acid and may provide rapid relief of dyspeptic symptoms.
They do not treat the underlying cause of H. pylori-associated disease and are not sufficient alone for healing significant ulcers.
However, they may be used for temporary symptom relief in selected situations.
Mucosal Protective Agents
Certain medications help protect the gastrointestinal mucosa.
Sucralfate forms a protective barrier over damaged mucosal surfaces and may assist healing.
Bismuth-containing compounds may provide mucosal protection and also have activity against H. pylori as part of specific eradication regimens.
These medications may be used depending on the patient's diagnosis and treatment plan.
Helicobacter pylori Eradication Therapy
When peptic ulcer disease is associated with H. pylori, eradication of the infection is essential.
Treatment generally involves a combination of acid suppression therapy and multiple antimicrobial agents.
The exact regimen depends on local antibiotic resistance patterns, previous antibiotic exposure, medication allergies, and regional clinical guidelines.
Bismuth-based combination therapy is commonly used in many settings.
Treatment adherence is extremely important because incomplete therapy may result in persistent infection and contribute to antimicrobial resistance.
After treatment, confirmation of eradication is generally recommended using an appropriate test for active infection.
Successful eradication significantly reduces the risk of recurrent ulcer disease.
Management of NSAID-Associated Ulcers
When NSAIDs contribute to ulcer formation, the first step is to determine whether the NSAID can be discontinued.
If discontinuation is possible, stopping the medication reduces continued mucosal injury.
Acid suppression therapy, particularly with a proton pump inhibitor, is commonly used to promote healing.
If continued NSAID treatment is necessary, clinicians may consider strategies to reduce gastrointestinal risk.
These may include:
- Using the lowest effective NSAID dose
- Avoiding multiple NSAIDs
- Using gastroprotective medication
- Reviewing alternative pain management options
- Assessing for H. pylori
- Evaluating concurrent medications that increase bleeding risk
High-risk patients require particularly careful management.
Diet and Lifestyle Considerations
Dietary management should focus on reducing foods and behaviors that worsen symptoms rather than unnecessarily restricting all foods.
Spicy foods do not directly cause most peptic ulcers, but they may aggravate symptoms in some individuals.
Patients may benefit from avoiding foods that consistently trigger discomfort.
Smoking cessation is strongly encouraged because smoking can impair ulcer healing and increase recurrence.
Excessive alcohol consumption should be avoided because alcohol can irritate the gastrointestinal mucosa and worsen symptoms.
Regular meals may improve comfort for some individuals, although dietary recommendations should be individualized.
Patients should avoid taking NSAIDs without medical advice if they have a history of ulcer disease or gastrointestinal bleeding.
Complications of Peptic Ulcer Disease
Peptic ulcer disease can lead to serious complications.
The four major complications are:
- Gastrointestinal bleeding
- Perforation
- Penetration
- Gastric outlet obstruction
These complications may require emergency treatment.
Gastrointestinal Bleeding
Bleeding is one of the most common serious complications of peptic ulcer disease.
An ulcer may erode into a blood vessel within the gastrointestinal wall.
The severity of bleeding depends on the size and location of the involved vessel.
Clinical manifestations include hematemesis, which is vomiting of blood, and melena, which produces black, tarry stools.
Massive bleeding may cause hypotension, tachycardia, dizziness, syncope, shock, and altered mental status.
Initial management involves assessment of airway, breathing, circulation, and hemodynamic stability.
Intravenous access, fluid resuscitation, blood testing, and blood transfusion may be required depending on severity.
Endoscopy plays a central role because it can identify the bleeding source and provide therapeutic intervention.
Acid suppression therapy is commonly used in the management of upper gastrointestinal ulcer bleeding.
Patients with severe or recurrent bleeding may require radiological intervention or surgery.
Perforation
Perforation occurs when an ulcer extends completely through the wall of the stomach or duodenum.
This allows gastric or intestinal contents to enter the peritoneal cavity.
The patient may experience sudden, severe abdominal pain.
The abdomen may become rigid and extremely tender because of peritonitis.
Perforation is a surgical emergency.
Imaging may demonstrate free air within the abdomen, particularly beneath the diaphragm.
Management involves rapid resuscitation, intravenous fluids, broad-spectrum antimicrobial therapy when indicated, acid suppression, and urgent surgical evaluation.
Penetration
Penetration occurs when an ulcer extends beyond the gastrointestinal wall into an adjacent organ.
For example, a posterior duodenal ulcer may penetrate into the pancreas.
Pain may become severe and persistent and may radiate toward the back.
The pattern of symptoms may change from the patient's usual ulcer discomfort.
Further diagnostic evaluation is required, and management depends on the severity and involved structures.
Gastric Outlet Obstruction
Chronic ulcer disease may cause inflammation, edema, or scarring near the gastric outlet or proximal duodenum.
This can obstruct the normal passage of gastric contents.
Symptoms may include persistent vomiting, abdominal fullness, early satiety, bloating, dehydration, and weight loss.
Vomiting may contain food eaten many hours earlier.
Management may involve correction of fluid and electrolyte abnormalities, gastric decompression, acid suppression, endoscopic procedures, and occasionally surgery.
Differential Diagnosis of Peptic Ulcer Disease
Several conditions can produce symptoms similar to peptic ulcer disease.
Gastroesophageal Reflux Disease
GERD commonly produces burning discomfort behind the sternum and acid regurgitation. Symptoms may worsen after meals or when lying down.
Gastritis
Gastritis involves inflammation of the gastric mucosa and can cause epigastric discomfort, nausea, and indigestion.
Functional Dyspepsia
Functional dyspepsia causes chronic upper abdominal discomfort without an identifiable structural disease explaining the symptoms.
Gallbladder Disease
Gallstones and gallbladder inflammation may cause upper abdominal pain, particularly after fatty meals.
Pancreatitis
Pancreatitis may produce severe epigastric pain radiating to the back, often associated with nausea and vomiting.
Cardiac Ischemia
Cardiac ischemia can occasionally present with epigastric discomfort rather than typical chest pain, particularly in older adults and individuals with diabetes.
For this reason, serious cardiac causes should be considered when appropriate.
Special Clinical Considerations
Peptic ulcer disease may present differently in older adults.
Elderly patients may have fewer typical symptoms and may present directly with bleeding, anemia, weakness, or perforation.
Patients taking anticoagulants or antiplatelet medications have an increased risk of serious bleeding.
Individuals with a previous history of ulcers require careful assessment before receiving NSAIDs.
Patients with recurrent ulcers despite appropriate therapy should be evaluated for persistent H. pylori, continued NSAID exposure, medication nonadherence, smoking, uncommon hypersecretory conditions, and alternative diagnoses.
Prevention of Peptic Ulcer Disease
Prevention focuses on reducing modifiable risk factors.
Avoid unnecessary NSAID use and use the lowest effective dose when these medications are required.
Patients at high gastrointestinal risk may require gastroprotective therapy.
Testing and treating H. pylori when clinically indicated can prevent recurrent ulcer disease.
Smoking cessation supports healing and reduces recurrence.
Patients with a previous history of gastrointestinal bleeding should discuss medication choices carefully with a healthcare professional.
Early recognition of warning symptoms is also important. Black stools, vomiting blood, fainting, severe abdominal pain, or persistent vomiting require urgent medical evaluation.
Prognosis and Long-Term Outlook
The prognosis for uncomplicated peptic ulcer disease is generally good when the underlying cause is identified and appropriately treated.
Ulcers associated with H. pylori often have a markedly reduced recurrence risk after successful eradication of the infection.
NSAID-associated ulcers can heal effectively when the offending medication is discontinued and appropriate acid suppression is provided.
However, recurrence remains possible if risk factors persist.
Long-term outcomes depend on medication exposure, successful eradication of H. pylori, smoking status, treatment adherence, and the presence of underlying medical conditions.
Regular follow-up may be necessary in selected patients, particularly those with gastric ulcers, recurrent symptoms, complicated ulcer disease, or persistent risk factors.
.jpeg)
